2023
DOI: 10.1016/j.fsi.2023.108805
|View full text |Cite
|
Sign up to set email alerts
|

Biofloc technology and immune response of penaeid shrimp: A meta-analysis and meta-regression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 56 publications
0
2
0
Order By: Relevance
“…In the biofloc technology, bacterial communities dominated by heterotrophic bacteria can be developed in aquaculture systems using appropriate carbon sources in suitable C:N ratios (Gaona et al, 2016). Ríos et al (2023) reported that C:N ratio of 10 significantly enhanced the immune stimulation in shrimp. Heterotrophic bacteria use organic carbon such as starch and sugar to generate energy and to grow into micro-biomass.…”
Section: Biofloc Technology (Bft)mentioning
confidence: 99%
“…In the biofloc technology, bacterial communities dominated by heterotrophic bacteria can be developed in aquaculture systems using appropriate carbon sources in suitable C:N ratios (Gaona et al, 2016). Ríos et al (2023) reported that C:N ratio of 10 significantly enhanced the immune stimulation in shrimp. Heterotrophic bacteria use organic carbon such as starch and sugar to generate energy and to grow into micro-biomass.…”
Section: Biofloc Technology (Bft)mentioning
confidence: 99%
“…That is why individual housing of the animals is preferred over group housing, as it allows for the sampling of individual shrimp at different timepoints to test an array of different immune parameters. Immune parameters that can be assessed in an in vivo challenge model in shrimp include the total hemocyte count (THC), differential hemocyte count (DHC), phagocytic index (PI), immune enzymes specific activity (phenoloxidase activity (POA), superoxide dismutase activity (SOD), Lysozyme activity (LZA), intracellular respiratory burst activity (IRB)), and the expression of known immune-related genes such as Hsp70, TGase, LYS, and ProPO [292,[328][329][330][331][332][333][334][335][336][337][338]. Once an immunostimulant has been tested in individual animals and efficacy has been established, it is advisable that the investigators also evaluate it in a group challenge model to further optimize the treatment under these conditions (refer to the sections Biologically Active Compounds and Antibody Therapy) (Table 4).…”
Section: Nonspecific Immunomodulatorsmentioning
confidence: 99%